Cannenta has signed a Heads of Agreement with Tianjin Medis

By | 2023-05-29T09:17:59+10:00 May 29th, 2023|

Cannenta has signed a Heads of Agreement with Tianjin Medis Continuing to build strategic engagements with value adding organisations around the world, Cannenta has signed a Heads of Agreement with Tianjin Medis for preparation and support in distributing wound care products in the Chinese market. Tianjin Medis is a successful medical products distribution business operating [...]

Cannenta has signed a Heads of Agreement with Nexgel Inc

By | 2023-05-29T09:10:07+10:00 May 29th, 2023|

Cannenta has signed a Heads of Agreement with Nexgel Inc Cannenta has signed a Heads of Agreement with US based manufacturer, Nexgel Inc. for the supply of wound dressings under contract for Cannenta. Initially, Nexgel will be providing quantities of their electron-beam crosslinked polymer hydrogels containing Cannenta’s unique factor, 2dDR for use in preclinical and [...]